| P50 | author | Alan S Go | Q89059120 |
| | Bruce H Fireman | Q90325741 |
| P2093 | author name string | Joe V Selby | |
| | David J Graham | |
| | Sengwee Toh | |
| | Jennifer C Nelson | |
| | Gregory W Daniel | |
| | Hylton V Joffe | |
| | Melissa G Butler | |
| P2860 | cites work | A Multiple Testing Procedure for Clinical Trials | Q28248823 |
| | A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes | Q28282265 |
| | A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance | Q29031025 |
| | Confounder summary scores when comparing the effects of multiple drug exposures | Q33566259 |
| | A basic study design for expedited safety signal evaluation based on electronic healthcare data | Q33648230 |
| | Invited commentary: propensity scores | Q33715877 |
| | Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases | Q34039973 |
| | Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone | Q34123137 |
| | Design considerations, architecture, and use of the Mini-Sentinel distributed data system | Q34133833 |
| | Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. | Q34514319 |
| | Indications for propensity scores and review of their use in pharmacoepidemiology | Q35623434 |
| | Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records | Q35816364 |
| | Design for validation of acute myocardial infarction cases in Mini-Sentinel | Q36921379 |
| | Use of disease risk scores in pharmacoepidemiologic studies | Q37194191 |
| | Influenza vaccination and mortality: differentiating vaccine effects from bias | Q37310234 |
| | Developing the Sentinel System--a national resource for evidence development | Q44120843 |
| | COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease | Q44182620 |
| | Interim analysis: the alpha spending function approach. | Q52881774 |
| | Evaluating Medication Effects Outside of Clinical Trials: New-User Designs | Q52956338 |
| | The central role of the propensity score in observational studies for causal effects | Q56882400 |
| P921 | main subject | myocardial infarction | Q12152 |
| | acute myocardial infarction | Q18558122 |
| P304 | page(s) | 282-290 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Pharmacoepidemiology and Drug Safety | Q15759496 |
| P1476 | title | A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent | |
| P478 | volume | 21 Suppl 1 | |